ERYTHROMYCIN ETHYLSUCCINATE
Generic: ERYTHROMYCIN
Amneal Pharmaceuticals NY LLCManufacturer
ORALRoute
ERYTHROMYCIN ETHYLSUCCINATEActive Substance
2019-11-01Original Approval
ERYTHROMYCIN ETHYLSUCCINATE is FDA application ANDA211204, sponsored by AMNEAL PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG HYPERSENSITIVITY
4,104 reports
2
NAUSEA
1,299 reports
3
VOMITING
1,133 reports
4
DIARRHOEA
1,089 reports
5
DRUG INEFFECTIVE
1,084 reports
6
DYSPNOEA
1,053 reports
7
FATIGUE
1,044 reports
8
RASH
1,029 reports
9
OFF LABEL USE
946 reports
10
HEADACHE
875 reports